University of Helsinki, Department of Medical and Clinical Genetics, Helsinki, Finland.
Medical Genetics, Department of Genomics, Laboratory Division, Turku University Hospital, Turku, Finland.
Acta Neurol Scand. 2022 Nov;146(5):643-651. doi: 10.1111/ane.13703. Epub 2022 Sep 9.
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a cerebral small vessel disease caused by pathogenic variants in the NOTCH3 gene. In Finland, the majority of CADASIL patients carry the pathogenic founder variant c.397C>T, (p.Arg133Cys), but the spectrum of other NOTCH3 variants has not been investigated previously. The aim of the study was to investigate the spectrum and prevalence of NOTCH3 variants Finnish CADASIL patients and to examine the clinical features associated with them.
The spectrum of NOTCH3 variants and the clinical features associated with them were retrospectively examined in 294 Finnish CADASIL patients tested during January 1996 to October 2021 in the Medical Genetics laboratory of Department of Genomics of Turku University Hospital, where practically all samples of patients with suspected CADASIL in Finland are investigated.
The most common NOTCH3 variants in the study cohort were c.397C>T, (p.Arg133Cys) (68%) and c.3206A>G p.(Tyr1069Cys) (18%), but other less common NOTCH3 variants were detected in as many as 14% of the patients. Eight of the detected NOTCH3 variants were novel: c.520T>A,p.(Cys174Ser), c.836A>G,p.(Gln279Arg), c.1369T>G,p.(Cys457Gly), c.1338C>G,p.(Cys446Trp), c.1564T>G,p.(Cys522Gly), c.2848T>G,p.(Cys950Gly), c.6102dup,p.(Gly2035Argfs*60), and c.2410+6C>G. Other NOTCH3 variants than p.Arg133Cys and p.Tyr1069Cys were more often associated with more severe clinical features.
This study revealed the genetic and clinical spectrum of CADASIL in the Finnish population. Sequencing of the whole NOTCH3 gene performing a gene-panel or exome sequencing is recommended when suspecting CADASIL.
脑常染色体显性动脉病伴皮质下梗死和白质脑病(CADASIL)是一种由 NOTCH3 基因突变引起的脑小血管疾病。在芬兰,大多数 CADASIL 患者携带致病性的创始人变体 c.397C>T,(p.Arg133Cys),但以前尚未研究过其他 NOTCH3 变体的谱。本研究旨在探讨芬兰 CADASIL 患者 NOTCH3 变体的谱及其与临床特征的相关性。
回顾性研究了 294 名芬兰 CADASIL 患者的 NOTCH3 变体谱及其与临床特征的相关性,这些患者于 1996 年 1 月至 2021 年 10 月在图尔库大学医院基因组学系医学遗传学实验室进行了检测,芬兰几乎所有疑似 CADASIL 患者的样本均在此处进行了检测。
在研究队列中,最常见的 NOTCH3 变体是 c.397C>T,(p.Arg133Cys)(68%)和 c.3206A>G p.(Tyr1069Cys)(18%),但在多达 14%的患者中检测到其他不太常见的 NOTCH3 变体。在检测到的 8 种 NOTCH3 变体中,有 8 种是新发现的:c.520T>A,p.(Cys174Ser),c.836A>G,p.(Gln279Arg),c.1369T>G,p.(Cys457Gly),c.1338C>G,p.(Cys446Trp),c.1564T>G,p.(Cys522Gly),c.2848T>G,p.(Cys950Gly),c.6102dup,p.(Gly2035Argfs*60),和 c.2410+6C>G。与 p.Arg133Cys 和 p.Tyr1069Cys 相比,其他 NOTCH3 变体更常与更严重的临床特征相关。
本研究揭示了芬兰人群中 CADASIL 的遗传和临床谱。当怀疑 CADASIL 时,建议进行全 NOTCH3 基因测序或外显子组测序。